Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.00
+0.18004.71%
Volume:306.90K
Turnover:1.22M
Market Cap:38.89M
PE:-0.12
High:4.05
Open:3.86
Low:3.82
Close:3.82
Loading ...

BRIEF-Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital

Reuters
·
21 Feb

What's Going On With Gene Therapy Company Bluebird Bio Stock Today?

Benzinga
·
21 Feb

BUZZ-Bluebird bio falls on discounted take private deal with Carlyle, SK Capital

Reuters
·
21 Feb

bluebird bio Shares Down 40% Premarket; Co to Be Acquired by Carlyle and SK Capital

THOMSON REUTERS
·
21 Feb

Bluebird bio to Be Acquired by Carlyle Group, SK Capital

Dow Jones
·
21 Feb

Gene therapy maker bluebird to go private in discounted deal amid cash crunch

Reuters
·
21 Feb

bluebird bio Agrees to be Acquired by Carlyle Group, SK Capital Partners; Trading Halted Pre-Bell

MT Newswires Live
·
21 Feb

Bluebird bio agrees to be acquired by Carlyle and SK Capital

Reuters
·
21 Feb

bluebird bio: Entered Into Amendments to Loan Agreement With Hercules Capital to Facilitate Adequate Liquidity

THOMSON REUTERS
·
21 Feb

bluebird bio Announces Definitive Agreement to Be Acquired by Carlyle and SK Capital

THOMSON REUTERS
·
21 Feb

bluebird bio Inc - Stockholders to Receive $3.00 per Share in Cash

THOMSON REUTERS
·
21 Feb

bluebird bio Inc - David Meek Expected to Become CEO of Bluebird Upon Closing of Deal

THOMSON REUTERS
·
21 Feb

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital

Business Wire
·
21 Feb

KIA EV9 AND TELLURIDE NAMED 2025 KELLEY BLUE BOOK BEST BUY AWARD WINNERS

PR Newswire
·
10 Feb

RBC Adjusts Price Target on bluebird bio to $8 From $80 Amid Reverse Stock Split, 'Limited Cash Runway,' Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
07 Jan

Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Bluebird Bio (BLUE)

TIPRANKS
·
07 Jan